UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3) 3
life sciences & biomedicine (3) 3
science & technology (3) 3
adult (2) 2
analysis (2) 2
clinical medicine (2) 2
clinical trials (2) 2
female (2) 2
insulin (2) 2
medicine (2) 2
pregnancy (2) 2
pregnant women (2) 2
treatment outcome (2) 2
type 1 diabetes (2) 2
abridged index medicus (1) 1
anestesi och intensivvård (1) 1
anesthesiology and intensive care (1) 1
autoimmune diseases (1) 1
back pain (1) 1
biological and medical sciences (1) 1
blood flow (1) 1
blood glucose - analysis (1) 1
blood glucose - drug effects (1) 1
blood glucose - metabolism (1) 1
body mass index (1) 1
body weight - drug effects (1) 1
body weight loss (1) 1
cerebral angiography - methods (1) 1
cerebral arteries - diagnostic imaging (1) 1
cerebral arteries - drug effects (1) 1
cerebral arteries - physiopathology (1) 1
cerebral ischemia (1) 1
cerebrovascular circulation - drug effects (1) 1
classification (1) 1
delayed (1) 1
delayed ischaemic neurological deficit (1) 1
denmark (1) 1
diabetes (1) 1
diabetes mellitus (1) 1
diabetes mellitus, type 1 - complications (1) 1
diabetes mellitus, type 1 - drug therapy (1) 1
diabetes mellitus, type 1 - epidemiology (1) 1
diabetes mellitus, type 2 - diagnosis (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diabetes therapy (1) 1
diabetes. impaired glucose tolerance (1) 1
diagnosis (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
endocrine pancreas. apud cells (1) 1
endocrinology & metabolism (1) 1
endocrinopathies (1) 1
epoprostenol (1) 1
epoprostenol - administration & dosage (1) 1
etiopathogenesis. screening. investigations. target tissue resistance (1) 1
evaluation (1) 1
evidence-based medicine (1) 1
exercise (1) 1
food and nutrition (1) 1
gallbladder diseases (1) 1
gastrointestinal surgery (1) 1
general & internal medicine (1) 1
glasgow coma scale (1) 1
glucagon-like peptide 1 - analogs & derivatives (1) 1
glucagon-like peptide 1 - pharmacology (1) 1
glucagon-like peptide-1 receptor - administration & dosage (1) 1
glucagon-like peptide-1 receptor - agonists (1) 1
glucose (1) 1
glucose metabolism (1) 1
health risks (1) 1
hemoglobin (1) 1
human health and pathology (1) 1
human medicine (1) 1
hypertension (1) 1
hypoglycemia - epidemiology (1) 1
hypoglycemic agents - therapeutic use (1) 1
immunology (1) 1
incidence (1) 1
incretins - therapeutic use (1) 1
infusions, parenteral (1) 1
injections, subcutaneous (1) 1
insulin - administration & dosage (1) 1
insulin - analogs & derivatives (1) 1
insulin - physiology (1) 1
insulin aspart (1) 1
insulin coma - epidemiology (1) 1
internal medicine (1) 1
investigations (1) 1
ischaemic neurological deficit (1) 1
klinisk medicin (1) 1
life sciences (1) 1
liraglutide - administration & dosage (1) 1
liraglutide - adverse effects (1) 1
liraglutide - pharmacology (1) 1
male (1) 1
medical and health sciences (1) 1
medical research (1) 1
medical sciences (1) 1
medicin och hälsovetenskap (1) 1
medicine, experimental (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Trials, ISSN 1745-6215, 07/2012, Volume 13, Issue 1, pp. 102 - 102
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10077, pp. 1399 - 1409
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Obesity - drug therapy | Glucagon-Like Peptide-1 Receptor - administration & dosage | Humans | Middle Aged | Body Weight - drug effects | Male | Weight Loss - drug effects | Liraglutide - pharmacology | Injections, Subcutaneous | Adult | Female | Placebos - administration & dosage | Body Mass Index | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Risk Reduction Behavior | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Glucagon-Like Peptide 1 - pharmacology | Prediabetic State - prevention & control | Treatment Outcome | Prediabetic State - complications | Blood Glucose - drug effects | Prediabetic State - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Liraglutide - adverse effects | Obesity - epidemiology | Placebos - pharmacology | Incretins - therapeutic use | Liraglutide - administration & dosage | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Type 2 diabetes | Clinical trials | Glucose metabolism | Risk factors | Prediabetic state | Diabetes therapy | Exercise | Obesity | Evaluation | Diabetes mellitus | Health risks | Weight loss | Glucose | Evidence-based medicine | Studies | Weight control | Randomization | Immunology | Classification | Weight reduction | Gastrointestinal surgery | Diabetes | Clinical medicine | Diagnosis | Autoimmune diseases | Risk management | Back pain | Physical activity | Gallbladder diseases | Body weight loss | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Hypertension | Risk reduction | Metabolism | Investigations | Nutrition research | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.